Need professional-grade analysis? Visit stockanalysis.com
$5.21B
25.05
1,947
1.73%
Getein Biotech Inc (603387) trades on SHG in CNY. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at CNY9.40, down 0.63% from the previous close.
Over the past year, 603387 has traded between a low of CNY7.65 and a high of CNY10.65. The stock has gained 17.5% over this period. It is currently 11.7% below its 52-week high.
Getein Biotech Inc has a market capitalization of $5.21B, with a price-to-earnings ratio of 25.05 and a dividend yield of 1.73%.
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic reagents and instruments in China and internationally. The company provides point-of-care detection, chemiluminescence detection, biochemical analysis, molecular testing, thrombus and hemostasis detection, blood cell analysis detection, urine analysis, quality control products, diagnostic raw materials, biochemical immunity, and other fields, such as myocardium, inflammation, renal function, thyroid function, hormones, glucose metabolism, tumor, coagulation, blood cells detection. The company was founded in 2002 and is headquartered in Nanjing, China.
Side-by-side comparison against top Healthcare peers.